Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

PROCEPT BioRobotics Sees FY2026 Sales $410.000M-$430.000M vs $427.376M Est

Author: Benzinga Newsdesk | November 04, 2025 04:08pm
PROCEPT BioRobotics (NASDAQ:PRCT) sees FY2026 sales of $410.000 million-$430.000 million vs $427.376 million analyst estimate.

Posted In: PRCT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist